Evaluation of a tetravalent dengue vaccine by serostatus and serotype

Saved in:
Bibliographic Details
Main Author: Wilder-Smith, Annelies (Author)
Format: Article (Journal) Editorial
Language:English
Published: [Mar 17, 2020]
In: The lancet
Year: 2020, Volume: 395, Issue: 10234, Pages: 1402-1404
ISSN:1474-547X
DOI:10.1016/S0140-6736(20)30603-6
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S0140-6736(20)30603-6
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0140673620306036
Get full text
Author Notes:Annelies Wilder-Smith
Description
Item Description:Gesehen am 22.06.2020
Refers to: Shibadas Biswal et al.: Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial, The Lancet, Volume 395, Issue 10234, 2-8 May 2020, Pages 1423-1433
Physical Description:Online Resource
ISSN:1474-547X
DOI:10.1016/S0140-6736(20)30603-6